| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,740,000 | 1,745,000 | 1,595,000 | 3,810,000 | | Cost of Revenue | (68,000) | 873,000 | 851,000 | 1,089,000 | | | Gross Profit | 2,808,000 | 872,000 | 744,000 | 2,721,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 436,000 | 406,000 | 359,000 | 393,000 | | Non Recurring | 818,000 | 23,000 | 51,000 | 156,000 | | Others | 909,000 | 933,000 | 806,000 | 756,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 645,000 | (490,000) | (472,000) | 1,416,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,000 | 344,000 | 108,000 | (56,000) | | Earnings Before Interest And Taxes | 532,000 | (146,000) | (364,000) | 1,352,000 | | Interest Expense | 121,000 | 203,000 | 181,000 | 184,000 | | Income Before Tax | 411,000 | (349,000) | (545,000) | 1,168,000 | | Income Tax Expense | 207,000 | (135,000) | (214,000) | 387,000 | | Minority Interest |
-
|
-
|
-
| (8,000) | | | | Net Income From Continuing Ops | 204,000 | (214,000) | (331,000) | 781,000 | | | Non-recurring Events | | Discontinued Operations | 2,000 | (2,000) |
-
| 5,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 206,000 | (216,000) | (331,000) | 786,000 | | Preferred Stock And Other Adjustments |
-
| (10,000) | (7,000) |
-
| | | Net Income Applicable To Common Shares | $200,000 | ($226,000) | ($338,000) | $786,000 |
|
0.34% Nasdaq 
1.14 (1.88%) 
Income Statement
